Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women with 18 years or over
Patients with disseminated breast cancer histologically or cytological confirmed, who begins with Her 2+ metastatic breast cancer or develops a metastasis after or during the adjuvant therapy
Patients treated in first line treatment in metastatic disease.
Patients who have positive Her 2 receptor test
Patients who have given their written informed consent
You may not be if
Patients who are participating in other studies
Clareo Health | Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy
